Quarterly report pursuant to Section 13 or 15(d)

Notes Payable (Narrative) (Details)

v3.5.0.2
Notes Payable (Narrative) (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Oct. 31, 2016
USD ($)
Oct. 07, 2016
USD ($)
Jul. 02, 2016
Jun. 22, 2016
USD ($)
May 31, 2016
USD ($)
Sep. 30, 2016
USD ($)
Sep. 30, 2016
USD ($)
Sep. 30, 2015
USD ($)
Sep. 30, 2016
USD ($)
Sep. 30, 2015
USD ($)
Aug. 01, 2016
USD ($)
Jun. 30, 2016
USD ($)
Jun. 28, 2016
USD ($)
May 31, 2015
USD ($)
May 15, 2015
USD ($)
Jul. 31, 2012
USD ($)
Debt Instrument [Line Items]                                
Compounded interest on notes payable             $ 190,000 $ 802,000 $ 1,367,259 $ 1,231,125            
Notes payable           $ 62,200,000 62,200,000   62,200,000              
Change in fair value of financial instruments             (839,298) (1,577,275) 1,755,989 (1,702,902)            
Net interest expense             2,600,000 2,100,000 12,300,000 4,700,000            
Interest expense recorded related to amortization             0 65,000 $ 77,964 423,522            
R-NAV [Member]                                
Debt Instrument [Line Items]                                
Joint venture, effective date of termination                 May 31, 2016              
Remaining amount on promissory note forgiven         $ 333,333                      
Platinum Credit Facility [Member]                                
Debt Instrument [Line Items]                                
Maximum borrowing capacity, amount                               $ 50,000,000
Current borrowing capacity                               $ 35,000,000
Compounded interest on notes payable                 $ 814,000              
Percentage of interest forgiven on credit facility     6.00%                          
Debt instrument effective rate                 In accordance with the terms of a Section 16(b) Settlement Agreement, Platinum agreed to forgive interest owed on the credit facility in an amount equal to 6%, effective July 1, 2016.              
Notes payable           9,300,000 9,300,000   $ 9,300,000              
Remaining borrowing capacity           27,300,000 27,300,000   27,300,000              
Unused additional borrowing capacity           15,000,000 15,000,000   15,000,000              
Platinum notes payable           1,300,000 1,300,000   1,300,000              
Change in fair value of financial instruments             839,000 $ 1,600,000 (1,800,000) $ 1,700,000            
Estimated fair value           10,500,000 10,500,000   10,500,000              
Capital Royalty Partners II LP [Member]                                
Debt Instrument [Line Items]                                
Compounded interest on notes payable                 553,000              
Notes payable           51,700,000 51,700,000   $ 51,700,000              
Debt instrument face amount                           $ 50,000,000    
Debt instrument, unused borrowing capacity                           $ 10,000,000    
Payment terms                 2 years              
Debt discount related to lender fees and other costs                             $ 2,200,000  
End-of-term fee amount           1,000,000 1,000,000   $ 1,000,000           1,000,000  
Minimum amount of yearly EBITDA required under agreement                 5,000,000              
Minimum sales revenue target                 $ 22,500,000              
Minimum sales revenue target in 2020                             45,000,000  
Cure right ratio                 2.5              
Liquidity minimum           $ 5,000,000 $ 5,000,000   $ 5,000,000           $ 5,000,000  
Debt instrument default interest rate percentage           18.00% 18.00%   18.00%              
Debt instrument, interest rate           14.00% 14.00%   14.00%              
Claims made from primary bank accounts on default       $ 4,100,000                        
Cash adjusted to collection of collateral, on claims of default       778,000         $ 778,000              
Cash adjusted to prepayment premium, on claims of default       2,100,000         2,100,000              
Cash adjusted to backend facility fee, on claims of default       1,000,000                        
Cash adjusted to principal balance of debt on default       $ 189,000                        
Notes payable, discounts                       $ 2,000,000        
Amount required to maintain in pledged collateral account subject to account control agreement           $ 2,500,000                    
Capital Royalty Partners II LP [Member] | Cardinal Health [Member]                                
Debt Instrument [Line Items]                                
Payments being placed in escrow with the court                     $ 1,000,000   $ 1,000,000      
Capital Royalty Partners II LP [Member] | Subsequent Event [Member]                                
Debt Instrument [Line Items]                                
Additional amount required to maintain as per ATI in pledged collateral account $ 500,000                              
Maximum days to place additional amount in pledged collateral account 10 days                              
Quarterly interest payments   $ 1,300,000                            
Capital Royalty Partners II LP [Member] | Subsequent Event [Member] | Cardinal Health [Member]                                
Debt Instrument [Line Items]                                
Percentage of receivables due 100.00%                              
Additional amount deposited in pledged collateral account as bond $ 1,000,000                              
Amount transferred from collateral bond to pledged collateral account $ 1,000,000 $ 1,000,000                            
Capital Royalty Partners II LP [Member] | Accrued Liabilities and Other [Member]                                
Debt Instrument [Line Items]                                
Accrued interest           $ 4,700,000 $ 4,700,000   $ 4,700,000